Physician profile
Patrick J Burns
NPI 1639140866
$2,098.91
in general payments reported to CMS, 2019-2025
32 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $207 · 2021: $581 · 2022: $418 · 2023: $405 · 2024: $77.69 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $284.10 | 2019-2024 | Relistor |
| Abbott Laboratories | $238.96 | 2021-2025 | Proclaim, Optis |
| Medtronic, INC. | $141.93 | 2022-2023 | Intellis Adaptivestim |
| Abbvie INC. | $131.54 | 2021-2023 | Ubrelvy, Qulipta |
| Stryker Corporation | $128.02 | 2025 | Augment Injectable |
| Vertos Medical, INC. | $123.34 | 2021 | |
| Redhill Biopharma INC. | $113.23 | 2020-2022 | |
| Boston Scientific Corporation | $105.64 | 2021-2025 | General - Pain Management, Bionic Navigator |
| Amgen INC. | $96.51 | 2020-2022 | |
| Lilly USA, LLC | $91.72 | 2022-2023 | Reyvow, Emgality |
| Cook Medical LLC | $68.91 | 2019 | |
| Radius Health, INC. | $48.09 | 2021 | |
| Novartis Pharmaceuticals Corporation | $47.79 | 2020 | |
| Almatica Pharma LLC | $45.02 | 2021 | |
| Collegium Pharmaceutical, INC. | $43.30 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $38.19 | 2020-2022 | |
| Lundbeck LLC | $37.57 | 2022-2023 | Vyepti |
| Mdd US Operations, LLC | $37.03 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.77 | 2019-2020 | |
| Grt US Holding, INC. | $28.28 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.47 | 2021 | |
| Pfizer INC. | $23.79 | 2019 | |
| Allergan, INC. | $22.70 | 2019 | |
| Nevro Corp. | $20.58 | 2021 | |
| Azurity Pharmaceuticals, INC. | $20.41 | 2023 | Horizant |
| Alnylam Pharmaceuticals INC. | $19.03 | 2024 | Givlaari |
| Kowa Pharmaceuticals America, INC. | $18.67 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.39 | 2020 | |
| Medtronic USA, INC. | $14.95 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.19 | 2023 | Ztlido |
| Forte Bio-Pharma LLC | $13.13 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.